Clinical trial
Platelet Membrane-coated Tenecteplase to Improve Thrombolytic Efficacy by Targeting Thrombus
NCT07712445 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Platelet Membrane-coated Tenecteplase to Improve Thrombolytic Efficacy by Targeting Thrombus
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 30, 2026
- Completion date
- July 30, 2027
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arterial thrombosis